Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer

Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer

NCT05845268 ·Status: RECRUITING ·Phase: PHASE2

The Prognostic Impact Of The Neutrophil To Lymphocyte Ratio In Patients With Locally Advanced Rectal Cancer

NCT05673343 ·Status: UNKNOWN

Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays

NCT02407561 ·Status: TERMINATED

Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer

NCT06883084 ·Status: ENROLLING_BY_INVITATION

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma

NCT05835960 ·Status: UNKNOWN

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

NCT05479240 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

NCT00960427 ·Status: WITHDRAWN ·Phase: PHASE1

Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial

NCT05877352 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Prognostic Value of PARS Classification for Locally Recurrent Rectal Cancer

NCT06808308 ·Status: COMPLETED

Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test.

NCT03699410 ·Status: TERMINATED

Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer

NCT05799443 ·Status: UNKNOWN ·Phase: PHASE2

Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission

NCT05964530 ·Status: RECRUITING ·Phase: NA

Neoadjuvant Chemoradiotherapy Combined With Immunotherapy and Anti-angiogenesis in Treating Locally Advanced Rectal Cancer

NCT07134218 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

NCT05628038 ·Status: RECRUITING ·Phase: PHASE2

Sentinel Lymph Node Mapping in Rectal Cancer

NCT02869152 ·Status: UNKNOWN ·Phase: NA

A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer

NCT04852653 ·Status: ACTIVE_NOT_RECRUITING

Functional Outcomes Following Anal Cancer Treatment

NCT01853059 ·Status: UNKNOWN

Maintenance Chemotherapy After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer

NCT01613469 ·Status: TERMINATED ·Phase: PHASE2

Rectal Sparing Approach After Preoperative Radio and/or Chemotherapy in Patients With Rectal Cancer

NCT02710812 ·Status: UNKNOWN

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

NCT05496491 ·Status: RECRUITING ·Phase: NA

Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

NCT05998122 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Immunomonitoring and Biomarker Research in Patients With Squamous Cell Anal Carcinoma

NCT03942900 ·Status: WITHDRAWN

Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer

NCT04906044 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC

NCT05575635 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2